(Q45762583)

15 December 2017

title

Size and conformational stability of the hepatitis A virus used to prepare VAQTA, a highly purified inactivated vaccine (English)

1 reference

15 December 2017

1 reference

1 reference

Volkin DB

1

1 reference

15 December 2017

Burke CJ

2

1 reference

15 December 2017

Marfia KE

3

1 reference

15 December 2017

Oswald CB

4

1 reference

15 December 2017

Wolanski B

5

1 reference

15 December 2017

Middaugh CR

6

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 June 1997

1 reference

15 December 2017

Journal of Pharmaceutical Sciences

published in

1 reference

15 December 2017

volume

86

1 reference

15 December 2017

issue

6

1 reference

15 December 2017

page(s)

666-673

1 reference

15 December 2017

Hepatitis A virus and hepatitis A infection

cites work

1 reference

7 January 2021

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

1 reference

7 January 2021

Development of the formalin-inactivated hepatitis A vaccine, VAQTA from the live attenuated virus strain CR326F.

1 reference

7 January 2021

Optimization of poly(ethylene glycol) precipitation of hepatitis A virus used to prepare VAQTA, a highly purified inactivated vaccine

1 reference

7 January 2021

Biophysical and Biochemical Characterization of Hepatitis A Virus

1 reference

7 January 2021

Characterization of hepatitis A virus structural proteins

1 reference

7 January 2021

The Physicochemical Properties of Infectious Hepatitis A Virions

1 reference

7 January 2021

Stability of Hepatitis A Virus

1 reference

7 January 2021

The heat sensitivity of hepatitis A virus determined by a simple tissue culture method

1 reference

7 January 2021

Cytopathology, plaque assay, and heat inactivation of hepatitis A virus strain HM175.

1 reference

7 January 2021

Acid stability of hepatitis A virus

1 reference

7 January 2021

Stabilising oral poliovaccine at high ambient temperatures

1 reference

7 January 2021

Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccines

1 reference

7 January 2021

Antigenicity of hepatitis A virus after ultra-violet inactivation

1 reference

7 January 2021

Approaches to a vaccine against hepatitis A: development and manufacture of an inactivated vaccine

1 reference

7 January 2021

Boundary analysis in sedimentation transport experiments: a procedure for obtaining sedimentation coefficient distributions using the time derivative of the concentration profile

1 reference

7 January 2021

Prediction of secondary structure, spatial organization and distribution of antigenic determinants for hepatitis A virus proteins

1 reference

7 January 2021

Three-dimensional structure of poliovirus at 2.9 A resolution.

1 reference

7 January 2021

Circular dichroism, molecular modeling, and serology indicate that the structural basis of antigenic variation in foot-and-mouth disease virus is alpha-helix formation

1 reference

7 January 2021

Lysine and other diamines dramatically stabilize poliovirus against thermoinactivation

1 reference

7 January 2021

Stabilization of human rhinovirus serotype 2 against pH-induced conformational change by antiviral compounds

1 reference

7 January 2021

Fluorescence spectrophotometric study of structural alterations in the capsid of poliovirus

1 reference

7 January 2021

Thermostabilization of live virus vaccines by heavy water (D2O).

1 reference

7 January 2021

Identifiers

DOI

10.1021/JS960475H

1 reference

15 December 2017

1 reference

15 December 2017